Johnson & Johnson MedTech today announced new data confirming the benefits of its Abiomed business' Impella CP system.
Patients with heart failure and adrenal insufficiency, compared with heart failure alone, have worse outcomes and a higher health care burden.
The “uneven playing field” related to demographics could be smoothed by stroke networks and standardized care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback